| Paul Larson, MD | |
|
721 American Avenue Suite 501, Phc Behavioral Medicine Center, Waukesha, WI 53188 | |
| (262) 928-2396 | |
| (262) 544-1213 |
| Full Name | Paul Larson |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Child & Adolescent Psychiatry |
| Location | 721 American Avenue Suite 501, Waukesha, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124091749 | NPI | - | NPPES |
| 34096900 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | 39093 (Wisconsin) | Primary |
| Entity Name | Madison Psychiatric Associates Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821026550 PECOS PAC ID: 1759286271 Enrollment ID: O20031205000710 |
News Archive
Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, has received a grant of US$500,000 for its on-going Phase II clinical trial of DIABECELL in New Zealand from the Juvenile Diabetes Research Foundation International, a world leader in setting the agenda for diabetes research and the largest charitable funder and advocate for research in type 1 diabetes.
As COVID-19 booster shots begin for those with compromised immune systems, researchers at the UC Davis School of Medicine continue to collect data from clinical trial participants.
ARMGO Pharma, Inc., a biopharmaceutical company developing innovative small molecule drugs known as "Rycals™," which act on the ryanodine receptor calcium-release channel (RyR), announced that a study published today in the prestigious scientific journal Cell reveals the underlying role of calcium leak through the RyR as an important contributor to stress-induced cognitive dysfunction.
Medflow, Inc., Medflow 2.0 EHR, Release 10 has achieved ONC HIT 2014 Edition COMPLETE EHR certification, which designates that the software is capable of supporting Eligible Providers with meeting the Stage 1 and Stage 2 Meaningful Use measures required to qualify for funding under the American Recovery and Reinvestment Act (ARRA).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paul Larson, MD 721 American Avenue Suite 501, Phc Behavioral Medicine Center, Waukesha, WI 53188 Ph: (262) 928-2396 | Paul Larson, MD 721 American Avenue Suite 501, Phc Behavioral Medicine Center, Waukesha, WI 53188 Ph: (262) 928-2396 |
News Archive
Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, has received a grant of US$500,000 for its on-going Phase II clinical trial of DIABECELL in New Zealand from the Juvenile Diabetes Research Foundation International, a world leader in setting the agenda for diabetes research and the largest charitable funder and advocate for research in type 1 diabetes.
As COVID-19 booster shots begin for those with compromised immune systems, researchers at the UC Davis School of Medicine continue to collect data from clinical trial participants.
ARMGO Pharma, Inc., a biopharmaceutical company developing innovative small molecule drugs known as "Rycals™," which act on the ryanodine receptor calcium-release channel (RyR), announced that a study published today in the prestigious scientific journal Cell reveals the underlying role of calcium leak through the RyR as an important contributor to stress-induced cognitive dysfunction.
Medflow, Inc., Medflow 2.0 EHR, Release 10 has achieved ONC HIT 2014 Edition COMPLETE EHR certification, which designates that the software is capable of supporting Eligible Providers with meeting the Stage 1 and Stage 2 Meaningful Use measures required to qualify for funding under the American Recovery and Reinvestment Act (ARRA).
› Verified 9 days ago
Dr. Thomas Jerome Wilson, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 500 Riverview Ave, Waukesha, WI 53188 Phone: 262-548-7666 Fax: 262-548-7656 | |
Dr. Malti Mahendra Patel, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 514 Riverview Ave, Waukesha, WI 53188 Phone: 262-548-7665 Fax: 262-970-6696 | |
Randall B Steinhaus, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 721 American Ave, Suite 501, Waukesha, WI 53188 Phone: 262-928-2396 | |
Dr. Stanya Smith, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1111 Delafield St Ste 105, Waukesha, WI 53188 Phone: 262-542-9503 Fax: 262-542-8447 | |
Gobind Kang-chahal, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 514 Riverview Ave, Waukesha, WI 53188 Phone: 262-548-7666 | |
Dr. Matthew R Herald, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 721 American Ave Ste 501, Waukesha, WI 53188 Phone: 262-928-7528 Fax: 262-928-5096 |